Richards, Merrill & Peterson, Inc. Amgen Inc Transaction History
Richards, Merrill & Peterson, Inc.
- $210 Billion
- Q2 2025
A detailed history of Richards, Merrill & Peterson, Inc. transactions in Amgen Inc stock. As of the latest transaction made, Richards, Merrill & Peterson, Inc. holds 1,176 shares of AMGN stock, worth $334,771. This represents 0.16% of its overall portfolio holdings.
Number of Shares
1,176
Previous 1,154
1.91%
Holding current value
$334,771
Previous $360 Million
8.67%
% of portfolio
0.16%
Previous 0.19%
Shares
3 transactions
Others Institutions Holding AMGN
# of Institutions
3,283Shares Held
427MCall Options Held
7.34MPut Options Held
7.43M-
Vanguard Group Inc Valley Forge, PA52.9MShares$15.1 Billion0.31% of portfolio
-
Black Rock Inc. New York, NY46MShares$13.1 Billion0.33% of portfolio
-
State Street Corp Boston, MA29.2MShares$8.31 Billion0.38% of portfolio
-
Capital World Investors Los Angeles, CA16.7MShares$4.75 Billion0.88% of portfolio
-
Morgan Stanley New York, NY16.2MShares$4.62 Billion0.37% of portfolio
About AMGEN INC
- Ticker AMGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 534,931,008
- Market Cap $152B
- Description
- Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...